Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros








Intervalo de ano de publicação
2.
Rev Esp Cardiol (Engl Ed) ; 70(11): 933-940, 2017 Nov.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28341414

RESUMO

INTRODUCTION AND OBJECTIVES: Myocardial interstitial fibrosis, a hallmark of hypertrophic cardiomyopathy (HCM), has been proposed as an arrhythmic substrate. Fibrosis is associated with increased extracellular volume (ECV), which can be quantified by computed tomography (CT). We aimed to analyze the association between CT-determined ECV and malignant ventricular arrhythmias. METHODS: A retrospective case-control observational study was conducted in HCM patients with implantable cardioverter-defibrillator, undergoing a CT-protocol with continuous iodine contrast infusion to determine equilibrium ECV. Left ventricular septal and lateral CT-determined ECV was compared between prespecified cases (malignant arrhythmia any time before CT scan) and controls (no prior malignant arrhythmias) and among ECV tertiles. RESULTS: A total of 78 implantable cardioverter-defibrillator HCM patients were included; 24 were women, with a mean age of 52.1 ± 15.6 years. Mean ECV ± standard deviation in the septal left ventricular wall and was 29.8% ± 6.3% in cases (n = 24) vs 31.9% ± 8.5% in controls (n = 54); P = .282. Mean ECV in the lateral wall was 24.5% ± 6.8% in cases vs 28.2% ± 7.4% in controls; P = .043. On comparison of the entire population according to septal ECV tertiles, no significant differences were found in the number of patients receiving appropriate shocks. Conversely, we found a trend (P = .056) for a higher number of patients receiving appropriate shocks in the lateral ECV lowest tertile. CONCLUSIONS: Extracellular volume was not increased in implantable cardioverter-defibrillator HCM patients with malignant ventricular arrhythmias vs those without arrhythmias. Our findings do not support the use of ECV (a surrogate of diffuse fibrosis) as a predictor of arrhythmias in high-risk HCM patients.


Assuntos
Arritmias Cardíacas/patologia , Cardiomiopatia Hipertrófica/patologia , Miocárdio/patologia , Arritmias Cardíacas/etiologia , Arritmias Cardíacas/terapia , Cardiomiopatia Hipertrófica/complicações , Estudos de Casos e Controles , Desfibriladores Implantáveis , Fibrose Endomiocárdica/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Variações Dependentes do Observador , Tamanho do Órgão/fisiologia , Estudos Prospectivos , Estudos Retrospectivos , Fatores de Risco , Tomografia Computadorizada por Raios X
3.
Rev Esp Cardiol (Engl Ed) ; 69(2): 149-58, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26507537

RESUMO

INTRODUCTION AND AIMS: Mutations in the troponin T gene (TTNT2) have been associated in small studies with the development of hypertrophic cardiomyopathy characterized by a high risk of sudden death and mild hypertrophy. We describe the clinical course of patients carrying mutations in this gene. METHODS: We analyzed the clinical characteristics and prognosis of patients with mutations in the TNNT2 gene who were seen in an inherited cardiac disease unit. RESULTS: Of 180 families with genetically studied cardiomyopathies, 21 families (11.7%) were identified as having mutations in TNNT2: 10 families had Arg92Gln, 5 had Arg286His, 3 had Arg278Cys, 1 had Arg92Trp, 1 had Arg94His, and 1 had Ile221Thr. Thirty-three additional genetic carriers were identified through family assessment. The study included 54 genetic carriers: 56% were male, and the mean average age was 41 ± 17 years. There were 33 cases of hypertrophic cardiomyopathy, 9 of dilated cardiomyopathy, and 1 of noncompaction cardiomyopathy, and maximal myocardial thickness was 18.5 ± 6mm. Ventricular dysfunction was present in 30% of individuals and a history of sudden death in 62%. During follow-up, 4 patients died and 14 (33%) received a defibrillator (8 probands, 6 relatives). Mean survival was 54 years. Carriers of Arg92Gln had early disease development, high penetrance, a high risk of sudden death, a high rate of defibrillator implantation, and a high frequency of mixed phenotype. CONCLUSIONS: Mutations in the TNNT2 gene were more common in this series than in previous studies. The clinical and prognostic profiles depended on the mutation present. Carriers of the Arg92Gln mutation developed hypertrophic or dilated cardiomyopathy and had a significantly worse prognosis than those with other mutations in TNNT2 or other sarcomeric genes.


Assuntos
Cardiomiopatia Dilatada/genética , Cardiomiopatia Hipertrófica/genética , Mutação/genética , Troponina T/genética , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Cardiomiopatia Dilatada/mortalidade , Cardiomiopatia Hipertrófica/mortalidade , Criança , Morte Súbita Cardíaca/etiologia , Intervalo Livre de Doença , Feminino , Efeito Fundador , Genótipo , Insuficiência Cardíaca/genética , Humanos , Masculino , Pessoa de Meia-Idade , Linhagem , Fenótipo , Prognóstico , Adulto Jovem
4.
Nutr Hosp ; 31(5): 2276-82, 2015 May 01.
Artigo em Espanhol | MEDLINE | ID: mdl-25929404

RESUMO

INTRODUCTION: Low energy intake may lead to the loss of muscle mass, menstrual dysfunction, increased risk of fatigue, injures and the need for prolonged recovery process. OBJECTIVES: 1) To analyse the adherence to the Mediterranean diet of a elite female athletes futsal population, 2) To analyse the relationship between the Dietary Mediterranean index, body composition and sport performance, and 3) To analyse if the differences in the index of adherence to the Mediterranean diet generates test differences in sports performance and body composition. METHODS: The adherence to a Mediterranean Diet, body composition test, isokinetic test, vertical jump test (CMJ and SJ), kicking ball, speed test and test Repeated Sprint Ability (RSA) was measured. RESULTS: we found that 7 out of 12 players (58.33%) showed a low index and 5 of the 12 players (41.67%) showed a means index. We found that 7 out of 12 players (58.33%) showed a low index and 5 of the 12 players (41.67%) below the optimum index. Moreover, this adhesion index did not correlate with the values of the body composition or athletic performance test. No significant differences between the players that scored below the optimal index with those with a low level of adhesion were observed. However, mass fat (%) correlated to the ability to repeat sprint. CONCLUSIONS: Low levels of adherence to the Mediterranean diet was observed in futsal players, the values shown in the KIDMED questionnaire did not correlate with the performance of the players nor body composition.


Introducción: Baja ingesta de energía puede dar lugar a la pérdida de masa muscular, disfunciones menstruales, un aumento del riesgo de la fatiga, lesión así como la necesidad de un proceso prolongado de recuperación. Objetivos: 1) Analizar el nivel de adherencia al Patrón de Dieta Mediterráneo en un grupo de mujeres deportistas profesionales de fútbol sala, 2) analizar el grado de relación entre el Patrón Dietético Mediterráneo, la composición corporal y el rendimiento deportivo y, 3) analizar si el actual grado de adherencia a la dieta mediterránea establece diferencias en los test de rendimiento deportivo y sobre la composición corporal. Métodos: Se valoró el PDM, test de composición corporal, test isocinético, test salto vertical (CMJ y SJ), golpeo de balón, test de velocidad y test Repeated Sprint Ability (RSA). Resultados: se observó que 7 de los 12 jugadoras (58,33%) mostró un patrón bajo y 5 de las 12 jugadoras (41,67%) un patrón medio. Por otro lado, estos patrones de adherencia no correlacionoraon con los valores de composición corporal ni con los test de rendimiento deportivo. No se observaron diferencias significativas entre las jugadoras que tenían un grado medio de adherencia con las que tenían un patrón bajo de adhesión. Sin embargo, la cantidad de grasa total (%) parece tener un efecto determinante en la capacidad de repetir sprint. Conclusión: Se observan bajos niveles de adhesión a la dieta mediterránea, los valores mostrados en el cuestionario KIDMED no se han relacionado con el rendimiento de las deportistas ni con el estado de la composición corporal.


Assuntos
Atletas , Desempenho Atlético , Dieta Mediterrânea , Comportamento Alimentar , Futebol , Composição Corporal/fisiologia , Feminino , Humanos , Corrida , Espanha , Adulto Jovem
5.
J Am Soc Echocardiogr ; 17(7): 717-22, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15220895

RESUMO

OBJECTIVE: Doppler tissue (DT) velocity abnormalities have been described in patients with pathologic left ventricular hypertrophy (LVH). Impaired myocardial function has been suggested as a primary disorder in hypertrophic cardiomyopathy (HCM) and differences in DT parameters have been reported to be distinguishable from other LVH causes. We evaluated DT differences for patients with LVH caused by hypertension and patients with HCM, assessing regional systolic and diastolic function. METHODS: A total of 62 participants were studied: 21 with HCM; 22 with LVH secondary to hypertension; and 19 control subjects. DT was used to record mitral annulobasal segment motion in the longitudinal axis. Systolic and diastolic velocities were measured at lateral and septal sites, and well-known ratios were obtained for diastolic assessment. A new global function index (GFI) that evaluates both systole and diastole was also calculated (GFI = [Emi/E(DT)]/S(DT) [s x cm(-1)], where mi is mitral inflow, E is E wave, and S is systolic wave). RESULTS: Comparison showed significant differences in all parameters evaluated at the septal-basal segment and a GFI value of 1.77 showed 85% sensitivity and 75% specificity for detecting HCM when interventricular septum thickness was increased. CONCLUSIONS: In the presence of unexplained LVH, markedly decreased DT velocities at basal septum efficiently detect myocardial dysfunction at this segment, and a calculated GFI > 1.77 strongly supports the diagnosis of HCM.


Assuntos
Cardiomiopatia Hipertrófica/diagnóstico por imagem , Diástole/fisiologia , Hipertensão/complicações , Hipertrofia Ventricular Esquerda/diagnóstico por imagem , Sístole/fisiologia , Feminino , Humanos , Hipertrofia Ventricular Esquerda/etiologia , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA